about
Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancerTranscriptome sequencing to detect gene fusions in cancerGenomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancerA common molecular basis for rearrangement disorders on chromosome 22q11Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastasesRCP is a human breast cancer-promoting gene with Ras-activating functionDeregulation of the carbohydrate (chondroitin 4) sulfotransferase 11 (CHST11) gene in a B-cell chronic lymphocytic leukemia with a t(12;14)(q23;q32)Expressed pseudogenes in the transcriptional landscape of human cancersFusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs)Whole-genome cartography of estrogen receptor alpha binding sites.Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.Extensive survey of STAT6 expression in a large series of mesenchymal tumors.A subset of solitary fibrous tumors express nuclear PAX8 and PAX2: a potential diagnostic pitfall.Inherent signals in sequencing-based Chromatin-ImmunoPrecipitation control libraries.An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer.Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer.Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanomaTRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancerUsefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumors.BCL8 is a novel, evolutionarily conserved human gene family encoding proteins with presumptive protein kinase A anchoring function.Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.Identification of a novel germline SPOP mutation in a family with hereditary prostate cancer.Activation of NF-{kappa}B by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4.Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells.Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes.Induced chromosomal proximity and gene fusions in prostate cancer.Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progressionThe tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinomaCoordinated regulation of polycomb group complexes through microRNAs in cancer.Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferaseInteraction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.Characterization of KRAS rearrangements in metastatic prostate cancer.Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer.Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics.The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma.RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC.Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer
P50
Q24302687-F2756DA9-C450-4AB8-83B1-E00F1F2EA09BQ24653386-378EFAB9-94D4-4929-8441-FD940E59BA43Q24675639-DBC986F4-DA55-480F-BE40-0AD816887299Q28137663-D453C432-D0E4-4E00-8E98-B0C94F26D299Q28244510-0DBC6397-506D-4CB1-8EA7-173FDDAC44D9Q28247245-25A3E403-3860-450F-B92A-F9141FA0111AQ28252569-35B5D5E4-9ED1-4445-A5BC-51397E9D6EC4Q28273746-C0F71671-E709-4FE8-8B19-11E9B0FA3391Q28703606-D5E8310D-7D63-4DCE-817B-4B5703BFC96CQ28757561-7290E373-A392-4059-860D-582E795B7FF9Q33286418-477A90C7-B078-426D-BDF6-FD28C487647DQ33362465-E1230D04-D11E-47B2-9421-C81B6E374A00Q33421985-707D8CC0-1124-4AE7-95C2-68D814DB0E2CQ33426197-E30B8201-0A5B-4A4F-AA9C-D40F09BC48ACQ33430252-7BA2E450-F3EB-4AC6-A682-D962A376C3C9Q33514281-5E352B96-D9FA-4C2A-BB28-537CD6A5A79DQ33949373-0087DEC2-5F91-455F-8274-F01F4CF8C4FEQ33992803-D4E2D821-EEC0-4B8D-A28D-2A201A782626Q34034240-C2E354DF-E6D8-4B75-83E5-789125047CE8Q34036819-FEFE94EB-6785-4AB6-A529-F69D6B26A7B1Q34142572-E949014B-B9D2-4E4B-8A86-1C0AB44820DEQ34158217-FA7899E9-6D2C-492D-BC3B-51CB1141A2D9Q34334347-72A3B1A1-D793-44D7-832B-2B8895D635F7Q34502671-99CFAF56-8679-409F-A234-EDBECC17EA7FQ34586640-A8E15EB8-8194-400C-89EB-8D456058492AQ34617463-4E639CB1-70B4-4481-9936-856A6C617742Q34762165-B2E53689-911C-4B4D-80E3-7B77927CA04AQ35014197-73A794EE-35A6-499E-8547-EFAC41BB9720Q35154249-434FE21E-4362-4502-8405-B40F8878455EQ35159486-B00C6C40-85C7-4F6F-8C27-89585CA24463Q35167450-6789D7D0-2402-45AF-9F1E-58CF6633FDD3Q35478969-E8160E00-8324-4D82-8373-05CCC99DB94FQ35554127-4A25A31B-BB1C-408C-9A8D-712EA38620A5Q35581673-F83778A7-604D-4116-8FFF-98869FD05A58Q35600870-CACE2F26-0A29-4CDB-B956-849B06C5BB6BQ35632848-E3BC94BA-8CCD-4316-92EB-0F818300D989Q35987423-839C47C3-4E0A-404B-BC54-6786E2F691C4Q36070575-1C4E3FD2-9EB4-477D-9DB2-FD1F6FE71140Q36126403-8F9D6DCC-F927-4086-870D-421E313D3A03Q36200413-1469D61A-695E-4440-853E-C56C1F753B72
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nallasivam Palanisamy
@ast
Nallasivam Palanisamy
@en
Nallasivam Palanisamy
@es
Nallasivam Palanisamy
@nl
Nallasivam Palanisamy
@sl
type
label
Nallasivam Palanisamy
@ast
Nallasivam Palanisamy
@en
Nallasivam Palanisamy
@es
Nallasivam Palanisamy
@nl
Nallasivam Palanisamy
@sl
altLabel
Palanisamy N Nallasivam P, Sivam PN
@en
Sivam PN Nallasivam P
@en
prefLabel
Nallasivam Palanisamy
@ast
Nallasivam Palanisamy
@en
Nallasivam Palanisamy
@es
Nallasivam Palanisamy
@nl
Nallasivam Palanisamy
@sl
P108
P106
P1153
6603644701
P2038
Nallasivam_Palanisamy
P2798
P31
P496
0000-0002-0633-9772